You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 2, February 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (41)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Panic Disorder
 •Alert me on articles by topic

Induced Panic Attacks Shift {gamma}-Aminobutyric Acid Type A Receptor Modulatory Neuroactive Steroid Composition in Patients With Panic Disorder

Preliminary Results

Andreas Ströhle, MD; Elena Romeo, MD; Flavia di Michele, MD; Augusto Pasini, MD; Bettina Hermann, PhD; Gisela Gajewsky; Florian Holsboer, MD, PhD; Rainer Rupprecht, MD

Arch Gen Psychiatry. 2003;60:161-168.

Background  Certain metabolites of progesterone such as 3{alpha},5{alpha}-tetrahydroprogesterone (3{alpha},5{alpha}-THP; allopregnanolone) and 3{alpha},5{beta}-THP (pregnanolone) are potent, positive allosteric modulators of {gamma}-aminobutyric acid type A receptors. Although animal studies suggest anxiolytic properties of these endogenous modulators of central nervous excitability, no clinical data indicate whether they are also involved in the pathophysiology of anxiety disorders and panic attacks.

Methods  We quantified the concentrations of 3{alpha},5{alpha}-THP, 3{alpha},5{beta}-THP, the isomer 3{beta},5{alpha}-THP, and their precursors in the plasma of 10 patients with panic disorder and matched control subjects during panic attacks induced by means of sodium lactate and cholecystokinin tetrapeptide administration, using a highly sensitive gas chromatography–mass spectrometry analysis.

Results  Panic attacks induced by sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder were accompanied by pronounced decreases in the concentrations of 3{alpha},5{alpha}-THP and 3{alpha},5{beta}-THP and a concomitant increase in the concentrations of the functional antagonistic isomer 3{beta},5{alpha}-THP, findings that are compatible with a decreased {gamma}-aminobutyric acid–ergic tone. No changes in neuroactive steroid concentrations were observed after placebo administration in patients with panic disorder or after placebo, sodium lactate, or cholecystokinin tetrapeptide administration in controls.

Conclusions  The association between changes in plasma neuroactive steroid concentrations and experimentally induced panic attacks and the well-documented pharmacological properties of these compounds as {gamma}-aminobutyric acid type A receptor modulators suggest that neuroactive steroids may play a role in the pathophysiology of panic attacks in patients with panic disorder.


From the Max Planck Institute of Psychiatry, Munich, Germany (Drs Ströhle, Hermann, Holsboer, and Rupprecht and Ms Gajewsky); and Tor Vergata University, IRCCS Santa Lucia, Rome, Italy (Drs Romeo, di Michele, and Pasini). Dr Ströhle is now with the Department of Psychiatry and Psychotherapy, Charité Hospital, Humboldt University at Berlin, Berlin, Germany.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of Microsomal Retinol/Sterol Dehydrogenase-Like Short-Chain Dehydrogenases/Reductases in the Oxidation and Epimerization of 3{alpha}-Hydroxysteroids in Human Tissues
Belyaeva et al.
Endocrinology 2007;148:2148-2156.
ABSTRACT | FULL TEXT  

Angiotensin-II Is a Putative Neurotransmitter in Lactate-Induced Panic-Like Responses in Rats with Disruption of GABAergic Inhibition in the Dorsomedial Hypothalamus
Shekhar et al.
J. Neurosci. 2006;26:9205-9215.
ABSTRACT | FULL TEXT  

The Acute Antipanic Activity of Aerobic Exercise
Strohle et al.
Am. J. Psychiatry 2005;162:2376-2378.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.